Table 2 Levels of SETD2 mRNA expression (After CK19 normalisation) in each group of patients
Parameter | subgroups | No. | Median | Mean ± SD |
|---|---|---|---|---|
All samples | SETD2 all tissue | 153 | 27 | 85547 ± 498012 |
|  | Normal tissue | 33 | 406 | 414434 ± 1106629 |
|  | Tumor tissue | 120 | 17 | 20950 ± 37626 |
NPI | NPI1 | 68 | 11 | 8755 ± 26203 |
|  | NPI2 | 37 | 24 | 16517 ± 55868 |
|  | NPI3 | 15 | 3 | 318 ± 645 |
Grade | Grade1 | 23 | 3 | 2592 ± 9686 |
|  | Grade2 | 41 | 19 | 11942 ± 35360 |
|  | Grade3 | 56 | 26 | 11457 ± 44706 |
TNM staging | TNM1 | 69 | 4 | 8551 ± 29766 |
|  | TNM2 | 40 | 42 | 8578 ± 24043 |
|  | TNM3 | 7 | 0 | 174 ± 414 |
|  | TNM4 | 4 | 221 | 679 ± 1081 |
Clinical outcomes | Disease free | 81 | 13 | 12239 ± 43466 |
|  | Alive with Metastasis | 7 | 2 | 1983 ± 5142 |
|  | Local recurrence | 5 | 930 | 3513 ± 5683 |
|  | Died of Br Ca | 20 | 16 | 698 ± 1741 |
ER receptor status | ERą negative | 7 | 24 | 4742 ± 18706 |
|  | ERą positive | 26 | 41 | 14278 ± 46482 |
|  | ERβ negative | 62 | 6 | 1698 ± 4441 |
|  | ERβ positive | 17 | 27 | 13353 ± 43908 |